Technical Analysis for DAWN - Day One Biopharmaceuticals, Inc.

Grade Last Price % Change Price Change
D 13.93 -3.20% -0.46
DAWN closed down 3.2 percent on Monday, March 18, 2024, on approximately normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Down Down

Date Alert Name Type % Chg
New Downtrend Bearish 0.00%
Outside Day Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Inside Day Range Contraction -3.20%
Oversold Stochastic Weakness -3.20%
MACD Bearish Centerline Cross Bearish -1.83%
180 Bearish Setup Bearish Swing Setup -1.83%
Stochastic Reached Oversold Weakness -1.83%
Oversold Stochastic Weakness -1.83%
50 DMA Resistance Bearish -6.45%

   Recent Intraday Alerts

Alert Time
60 Minute Opening Range Breakdown about 14 hours ago
Outside Day about 14 hours ago
Fell Below Previous Day's Low about 14 hours ago
Rose Above Previous Day's High about 15 hours ago
Down 2 % about 15 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/progressive low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Enzymes Protein Kinase Inhibitor Signal Transduction Protein Kinase Kinase Fibrosarcoma Ym Biosciences

Is DAWN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 18.67
52 Week Low 9.67
Average Volume 555,842
200-Day Moving Average 13.26
50-Day Moving Average 14.96
20-Day Moving Average 15.56
10-Day Moving Average 15.08
Average True Range 0.82
RSI (14) 38.65
ADX 25.18
+DI 15.38
-DI 31.46
Chandelier Exit (Long, 3 ATRs) 15.39
Chandelier Exit (Short, 3 ATRs) 16.26
Upper Bollinger Bands 17.68
Lower Bollinger Band 13.44
Percent B (%b) 0.12
BandWidth 27.24
MACD Line -0.19
MACD Signal Line 0.11
MACD Histogram -0.3026
Fundamentals Value
Market Cap 1.21 Billion
Num Shares 87 Million
EPS -2.29
Price-to-Earnings (P/E) Ratio -6.08
Price-to-Sales 0.00
Price-to-Book 3.40
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 14.95
Resistance 3 (R3) 15.06 14.82 14.78
Resistance 2 (R2) 14.82 14.56 14.77 14.72
Resistance 1 (R1) 14.38 14.40 14.26 14.27 14.67
Pivot Point 14.14 14.14 14.08 14.09 14.14
Support 1 (S1) 13.70 13.88 13.58 13.59 13.19
Support 2 (S2) 13.46 13.72 13.41 13.14
Support 3 (S3) 13.02 13.46 13.08
Support 4 (S4) 12.91